NBC Securities
TVTX icon

NBC Securities’s Travere Therapeutics TVTX Stock Holding History

NBC Securities’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$238K Buy
4,050
+197
+5% +$12K 0.02% 804
2026
Q2 		$219K Buy
+3,853
New +$171K 0.01% 821
2025
Q4 		– Sell
-647
Closed -$15.5K – 2929
2025
Q3 		$15.5K Buy
647
+168
+35% +$3.16K ﹤0.01% 1866
2025
Q2 		$7K Hold
479
– – ﹤0.01% 2049
2025
Q1 		$8K Buy
+479
New +$9.7K ﹤0.01% 1791
2024
Q4 		– Sell
-479
Closed -$6K – 2020
2024
Q3 		$6K Hold
479
– – ﹤0.01% 1860
2024
Q2 		$3K Hold
479
– – ﹤0.01% 1956
2024
Q1 		$3K Hold
479
– – ﹤0.01% 1965
2023
Q4 		$4K Hold
479
– – ﹤0.01% 1926
2023
Q3 		$4K Buy
+479
New +$6.76K ﹤0.01% 1924

Other funds holding TVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

NBC Securities's TVTX Position: Q3 2026 in Review

NBC Securities increased its Travere Therapeutics (TVTX) stake by 5.1% in Q3 2026, buying an estimated $12K and bringing the position to 4,050 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #804.

NBC Securities first reported a position in TVTX in Q3 2023 and has held it in 10 quarters since. 158 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • NBC Securities held 4,050 shares of Travere Therapeutics worth $238K as of Q3 2026.
  • NBC Securities bought 197 Travere Therapeutics shares in Q3 2026, an estimated $12K.
  • Travere Therapeutics made up 0.02% of NBC Securities's portfolio in Q3 2026, its #804 holding.
  • NBC Securities first reported a position in Travere Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 158 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.